Q1 FY27 results analysis · August 04, 2026

Timken India Ltd Q1 FY27 Results Analysis: Revenue Surges 14.87%, EBITDA Margin Expands 94 bps

+10.5%PAT year on year, Rs. 115.13 Cr
Cofacto ResearchPublished August 04, 20262 min readPositive read
Quick summary

Timken India Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 929.09 Cr (+14.87% YoY) and PAT growth of +10.46% YoY. Here's a quick read of what worked, what to watch, and what management said.

Quick Details
Results dateAugust 04, 2026
QuarterQ1 FY 2026-2027
Revenue (Q1)Rs. 929.09 Cr (+14.87% YoY)
PAT (Q1)Rs. 115.13 Cr (+10.46% YoY)
EBITDA margin18.54% (+94 bps YoY)
EPS (Q1)Rs. 15.31 (+10.46% YoY)
Market capRs. 24,324.69 Cr
CMPRs. 3,231.90

Quarter Snapshot

Revenue grew 14.87% to a record Q1 high, EBITDA margins expanded 94 bps from price pass-through and operating leverage. Depreciation from Bharuch capex and higher tax rate capped reported PAT growth at 10.46%, but normalized PAT rose 16.45%. Zero-debt balance sheet and ongoing capacity expansions (Bharuch ramp-up, Jamshedpur rail) position the company for sustained growth.

Key Investment Insights

Key Positives

  • Revenue grew 14.87% YoY to Rs.929.09 Cr, highest-ever first quarter.
  • EBITDA grew 21.01% YoY to Rs.172.24 Cr, with margin expanding 94 bps to 18.54%.
  • Normalized PAT grew 16.45% YoY to Rs.111.76 Cr.
  • Net material cost as % of revenue improved 97 bps YoY to 60.09%, indicating successful price pass-through.
  • Zero-debt balance sheet with cash equivalents of Rs.268.5 Cr provides ample liquidity.
  • Consolidated PAT includes Rs.4.53 Cr from subsidiary, which is profitable.

Risk Factors

  • Depreciation surged 50.62% YoY to Rs.31.33 Cr due to Bharuch plant capitalisation, limiting PAT growth to 10.46% vs EBITDA growth of 21.01%.
  • Effective tax rate jumped 333 bps YoY to 23.42%, reducing net profit growth.
  • Other expenses grew 15.47% YoY, in line with revenue, indicating ongoing ramp-up costs from Bharuch.

Ask about this

Ask Cofacto a question about this result. Answers cite filings and company data.

Companies on this page

Related

Share on X · LinkedIn · WhatsApp

Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.